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Letter to the Editor
Re: Fredrick Leidberg, Petter Kollberg, Marie Allerbo,
et al. Preventing Parastomal Hernia After Ileal Conduit
by the Use of a Prophylactic Mesh: A Randomised
Study. Eur Urol 2020;78:757–63
We congratulate Leidberg and colleagues [1] on conducting
a well-designed randomized controlled trial to answer an
important clinical question: does prophylactic mesh placement at the time of radical cystectomy with urinary
diversion decrease the risk of parastomal hernia (PSH)?
At the cost of adding an extra hour to the operating time,
mesh placement decreased clinical PSH rates over a median
2-yr follow-up period (11%) compared to no mesh (23%). No
difference was noted, however, in terms of radiological PSH
(19% vs 25%) and the aforementioned findings were
confirmed on multivariable analyses. We would like to
shed light on some pertinent points that have direct
implications for these findings in clinical practice.

1 It would be helpful to more clearly define what
constitutes “clinical hernia”: the authors counted both
symptomatic and asymptomatic hernia as clinical PSH.
Given that this assessment was not blinded and rather
subjective, there could be an element of ascertainment
bias, as patients with mesh in place could be presumed to
be less likely to have a clinical hernia. Indeed, for the
mesh group, the rate of radiological PSH was higher than
the rate of clinical PSH (19% vs 11%), and was not
statistically significantly different from the no-mesh
group. It would also be interesting to see how many
had clinically symptomatic or significant PSH. For
patients in either arm deemed to have clinical PSH, the
rate of surgical intervention (if assumed as a proxy for
clinically significant PSH) was 25% (5/20) in no-mesh arm
and 20% (2/10) in the mesh arm. This suggests that most
of the clinical hernias may not have been clinically
significant, a finding that has also been noted by other
high-volume centers [2,3].
2 How did the authors differentiate parastomal bulge from
clinical PSH? It seems somewhat counterintuitive that
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the rates of bulging were higher in the mesh group (24%)
than in the no-mesh group (15%).
While the majority of radical cystectomies continue to be
performed either as an entirely open approach or with an
extracorporeal conduit, the lack of minimally invasive
approach in the study limits the generalizability to
patients undergoing robotic/laparoscopic approaches.
Ongoing clinical trials, some of which will include robotic
cystectomy patients or study modified approaches for
mesh placement, may provide more details, especially
since prophylactic mesh placement has not shown a
significant benefit in recent trials for patients receiving a
colostomy [4,5], including those undergoing laparoscopic
surgery [6].
Was the surgical approach otherwise standardized
across all participating institutions? Patients undergoing
surgery at one of the hospitals had more than three
times the risk of clinical hernia than others, and
interestingly this association was seen with radiological
PSH and parastomal bulging as well. Given that 60% of
patients did not undergo surgery at Skåne Hospital (the
reference standard, with presumably lowest rates of
PSH), these findings warrant closer assessment of
differences in preoperative patient selection, intraoperative differences, or postoperative care at the centers
that might play a bigger role than mesh placement itself
[2,3].
Less than half of all patients included underwent
preoperative chemotherapy, and a very small fraction
underwent previous laparotomy incisions/intra-abdominal surgeries. Both of these groups might arguably have
higher rates of PSH, and while current multivariable
analyses did not show an association between chemotherapy and hernia, the study might be underpowered to
detect these associations.
Lastly, do the authors have any details about the
190 patients who were excluded from this study? Did
they undergo mesh placement as well, and, if so, what
were their outcomes?
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